Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diltiazem in Preclinical Hypertrophic Cardiomyopathy
NCT00319982Phase 3Completed
- Sponsor
- Brigham and Women's Hospital
- Start
- Jan 2006
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diltiazem in hypertrophic cardiomyopathy (HCM), sponsored by Brigham and Women's Hospital. Started Jan 2006; status: completed.
02
Drugs
diltiazem
03
Conditions
hypertrophic cardiomyopathy (HCM)
Beyond the preview
Go deeper on NCT00319982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00319982.